The alternative protein race just got a new entrant: the pet food aisle. Finnish food tech startup Enifer has partnered with Rovio Pet Foods to bring Pekilo mycoprotein dog treats to market. For ingredient suppliers watching novel proteins cross into pet nutrition, this one is worth tracking.
TLDR
- Two Finnish startups co-developed a semi-moist mycoprotein dog treat.
- Enifer’s Pekilo ingredient is derived from fungal mycelium fermentation.
- Pet food is emerging as a testbed for alternative protein commercialization.
- The partnership signals a new channel for novel protein ingredient suppliers.
- Clean-label pet nutrition demand mirrors the human food trend.
Green Queen reports that Enifer, a Helsinki-based food tech company, has moved its mycelium-derived Pekilo protein beyond human food applications. The new partnership with Rovio Pet Foods targets the fast-growing premium pet treat segment.
What Is Pekilo and Why Does It Matter for Pet Food?
Pekilo mycoprotein dog treats represent a meaningful formulation milestone. Enifer produces its ingredient through continuous fermentation of the fungus Paecilomyces variotii. The process uses side streams from forest and agricultural industries as feedstock, giving it a sustainability profile that resonates with clean-label buyers.
Mycoprotein is already an established human food ingredient, most famously in Quorn products. However, pet food has lagged in adopting fungi-derived proteins at scale. Rovio’s semi-moist format is a practical entry point: the texture suits palatability requirements, and the category commands premium price points.
A New Channel Opens for Alternative Protein Suppliers
For ingredient suppliers and contract manufacturers, this partnership signals something structural. Pet humanization continues to drive demand for traceable, sustainable protein sources. Operators who have watched plant-based and fermentation-derived proteins struggle for shelf space in human food may find pet nutrition a lower-friction route to volume.
Enifer has not yet disclosed commercial scale or retail distribution details. Still, the move validates a broader pattern: novel protein startups are increasingly using pet food as a commercialization bridge. The Future of Food has tracked this trend across insect protein and single-cell protein categories.
Additionally, regulatory pathways for novel ingredients in pet food differ from human food in many markets, potentially accelerating speed to shelf. That asymmetry matters for startups managing capital and timelines.
Watch this. The companies that establish ingredient credibility in pet nutrition today are building the supply chain infrastructure that human food applications will eventually need.
Source: Green Queen. https://www.greenqueen.com.hk/enifer-pekilo-mycoprotein-dog-treats-rovio-pet-foods/